Search research articles
Contact Us
Filters
Showing results (21-30 of 35) with videos related to
Page
of 4
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 20, 2022
Tumor budding is an independent prognostic factor in stage III colon cancer patients: a post-hoc analysis of the IDEA-France phase III trial (PRODIGE-GERCOR)
D Basile, C Broudin, J F Emile, et al.
Oncogene
|
September 15, 2015
The HSP90 inhibitor, 17AAG, protects the intestinal stem cell niche and inhibits graft versus host disease development
A-L Joly, A Deepti, A Seignez, et al.
Oncogene
|
June 3, 2016
The HSP90 inhibitor, 17AAG, protects the intestinal stem cell niche and inhibits graft versus host disease development
A-L Joly, A Deepti, A Seignez, et al.
British Journal of Cancer
|
November 8, 2013
Small bowel adenocarcinoma phenotyping, a clinicobiological prognostic study
T Aparicio, M Svrcek, A Zaanan, et al.
Oncogene
|
November 8, 2016
HSP110 promotes colorectal cancer growth through STAT3 activation
K Berthenet, A'dem Bokhari, A Lagrange, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 23, 2017
Clinical and molecular characterisation of hereditary and sporadic metastatic colorectal cancers harbouring microsatellite instability/DNA mismatch repair deficiency
R Cohen, O Buhard, P Cervera, et al.
ESMO Open
|
April 30, 2021
Discordance between immunochemistry of mismatch repair proteins and molecular testing of microsatellite instability in colorectal cancer
A Guyot D'Asnières De Salins, G Tachon, R Cohen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 16, 2020
Prognostic and predictive value of the Immunoscore in stage III colon cancer patients treated with oxaliplatin in the prospective IDEA France PRODIGE-GERCOR cohort study
F Pagès, T André, J Taieb, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 2, 2012
Contribution of CXCR4 and SMAD4 in predicting disease progression pattern and benefit from adjuvant chemotherapy in resected pancreatic adenocarcinoma
J B Bachet, R Maréchal, P Demetter, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 22, 2021
Combining tumor deposits with the number of lymph node metastases to improve the prognostic accuracy in stage III colon cancer: a post hoc analysis of the CALGB/SWOG 80702 phase III study (Alliance)<sup>☆</sup>
R Cohen, Q Shi, J Meyers, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 35) with videos related to
Sort By:
Page
of 4
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 20, 2022
Tumor budding is an independent prognostic factor in stage III colon cancer patients: a post-hoc analysis of the IDEA-France phase III trial (PRODIGE-GERCOR)
D Basile, C Broudin, J F Emile, et al.
Oncogene
|
September 15, 2015
The HSP90 inhibitor, 17AAG, protects the intestinal stem cell niche and inhibits graft versus host disease development
A-L Joly, A Deepti, A Seignez, et al.
Oncogene
|
June 3, 2016
The HSP90 inhibitor, 17AAG, protects the intestinal stem cell niche and inhibits graft versus host disease development
A-L Joly, A Deepti, A Seignez, et al.
British Journal of Cancer
|
November 8, 2013
Small bowel adenocarcinoma phenotyping, a clinicobiological prognostic study
T Aparicio, M Svrcek, A Zaanan, et al.
Oncogene
|
November 8, 2016
HSP110 promotes colorectal cancer growth through STAT3 activation
K Berthenet, A'dem Bokhari, A Lagrange, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 23, 2017
Clinical and molecular characterisation of hereditary and sporadic metastatic colorectal cancers harbouring microsatellite instability/DNA mismatch repair deficiency
R Cohen, O Buhard, P Cervera, et al.
ESMO Open
|
April 30, 2021
Discordance between immunochemistry of mismatch repair proteins and molecular testing of microsatellite instability in colorectal cancer
A Guyot D'Asnières De Salins, G Tachon, R Cohen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 16, 2020
Prognostic and predictive value of the Immunoscore in stage III colon cancer patients treated with oxaliplatin in the prospective IDEA France PRODIGE-GERCOR cohort study
F Pagès, T André, J Taieb, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 2, 2012
Contribution of CXCR4 and SMAD4 in predicting disease progression pattern and benefit from adjuvant chemotherapy in resected pancreatic adenocarcinoma
J B Bachet, R Maréchal, P Demetter, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 22, 2021
Combining tumor deposits with the number of lymph node metastases to improve the prognostic accuracy in stage III colon cancer: a post hoc analysis of the CALGB/SWOG 80702 phase III study (Alliance)<sup>☆</sup>
R Cohen, Q Shi, J Meyers, et al.
Page
of 4